(1) The challenge of disease prevention and control is formidable.
In recent years, China's cardiovascular and cerebrovascular diseases, malignant tumors, diabetes and other chronic non-communicable diseases are on the rise and the trend of rejuvenation, has become the main cause of death of urban and rural residents in our country and bring a heavy medical burden. The incidence of major infectious diseases such as tuberculosis, AIDS and hepatitis remains high, and new infectious diseases such as SARS and influenza A (H1N1) continue to emerge, so the situation of prevention and control of infectious diseases is still very serious. While China has made great achievements in controlling the number of people, the problem of aging before getting rich has also emerged, and the prevention and treatment of diseases and health protection of the aging population have brought enormous economic pressure on society and families. In addition, birth defects have become a major social problem, psychological and mental disorders are increasing, major natural disasters and accidental injuries are frequent, common and frequent diseases such as respiratory and digestive diseases are still troubling the health of the general public, the impact of food safety and environmental hazards on health has increased, occupational and endemic diseases are highly prevalent, diseases of medical and medicinal origin are constantly appearing, the population of the subhealth state is expanding, and the diagnostic and treatment technology level of medical institutions in the rural and basic areas has been low, while the health care system in rural areas has become more advanced. The low level of diagnosis and treatment technology in medical institutions in rural areas has further aggravated the serious situation of disease prevention and control. In the face of many challenges, the existing level of medical knowledge is still very limited, many major diseases, including common diseases, still lack of cost-effective prevention and control methods and means of diagnosis and treatment, disease prevention and treatment of scientific and technological support capacity needs to be improved.
(2) The demand for health is growing rapidly.
Health is the most common and fundamental need of human beings. At this stage, the main characteristics of China's health needs are a low starting point, the total volume, the overall health of the population is relatively poor. With the continuous improvement of economic conditions, education, science and technology, industrial development and other elements of the level of the general public's health needs are rapidly released, people pay more and more attention to preventing and treating diseases, pulling the rapid development of medical services and biomedical industry, including drugs and medical devices, which also leads to the problem of shortage of medical resources in China is also becoming more and more prominent. At the same time, along with the continuous improvement of the general public's health awareness, family medicine, rehabilitation and health care, personal health and other products have gradually become a new market growth point, health care consumer spending in personal consumption expenditure accounted for a gradually increasing proportion of the rapid growth of the modern health services industry. The purpose of medical science and technology is no longer only to relieve the pain of illness, but also to meet the multi-level needs of people's health improvement and quality of life, and provide better health services.
(3) Science and technology innovation is highly active.
The endogenous impetus brought about by understanding the phenomenon of life and solving health problems, as well as the continuous advancement of multidisciplinary theories and methods mainly in life sciences, have contributed to the continuous expansion of the depth and breadth of medical research. Research at the level of molecules, cells, tissues, organs, systems and the whole continues to deepen, promoting the accelerated development of medicine in new directions such as prediction, prevention and individualized diagnosis and treatment; medical imaging, molecular diagnostics, gene therapy, cell therapy, minimally invasive surgery, tissue engineering, biomedical materials, targeted drug therapy, non-invasive testing, real-time monitoring, digital healthcare, telemedicine, mobile healthcare, and other new technologies continue to develop, and the means of disease prevention and treatment and medical care continue to expand. The development of medical science and technology has entered an important period of strategic opportunity.
(4) Accelerated transformation of the medical model.
With the deepening of scientific understanding, exploring the mysteries of life, revealing the nature of human health and disease, and seeking safer and more effective methods of intervention are not purely biomedical issues, but rather biological, environmental, psychological, social, and other complex systemic scientific issues, medical science and technology has entered the era of multi-faceted, all-encompassing study of holistic medicine, and medical science and technology development depends more and more on multidisciplinary, cross-field, and the development of medical science and technology. The development of medical science and technology depends more and more on the cross-penetration and integration of multidisciplinary and cross-field, as well as the closely coordinated large-scale military operation. Closely focusing on the development needs of medical science and technology, strengthening the integration of medical research resources, promoting the cross-fertilization of different disciplines and technical fields, facilitating the close connection of cutting-edge technology, basic research and clinical medicine, and accelerating the establishment of a holistic and synergistic research model is becoming a new development trend.
(E) Industrial competition is becoming increasingly fierce.
The health industry, led by innovative drug research and development and advanced medical device manufacturing, is an important foundation for supporting the construction of the national healthcare system and promoting the improvement of medical services, and is one of the most intense and important strategic high points that countries around the world are competing for. Under the dual impact of technology-driven and demand-driven, the global health industry continues to grow and develop rapidly, the United States has been in the world's leading position, Europe has shown a strong momentum of development, Japan has identified the "bio-industry as a country" strategic goal, China will also be biomedicine identified as the "Twelfth Five-Year" period to focus on the development of strategic development. China has also identified biopharmaceuticals as a strategic emerging industry to be developed during the "Twelfth Five-Year Plan" period. However, China's chemical and biological drugs are still mainly generic drugs, large and medium-sized, medium and high-end medical devices are mainly dependent on imports, and the development of traditional Chinese medicine industry is also facing many challenges such as resources and standards. Further efforts to accelerate the development of strategic emerging industries in biomedicine is not only an urgent need to support the construction of healthcare system and reduce the burden of public healthcare, but also a major strategic need for the development of future healthcare industry and the transformation of medical model.
(F) The strategic significance is becoming more and more prominent.
Medicine and health are related to social harmony, economic development and political stability, and all governments are focusing on the development of medical science and technology to solve the problems of preventing and controlling important diseases and to realize the goal of health care for all. The improvement of health level has become one of the important indicators for measuring and evaluating the social development status of each country, and many countries have already launched health strategies and are now implementing them, and the proportion of investment in medical research and development has been increasingly strengthened. The U.S. National Institutes of Health (NIH) research funding accounted for more than one-third of the U.S. non-defense field research funding, reached 31.2 billion U.S. dollars in 2010, and maintain a sustained growth trend; the United Kingdom plans to invest 15 billion pounds sterling in research and development in the field of cancer and other diseases within 10 years. Whether it is the total amount of investment funds or the proportion of science and technology funds, China's medical science and technology investment compared with developed countries there is still a big gap. Further increase the medical field of science and technology investment, accelerate the development of medical science and technology, has great strategic significance.